Recently, at the annual DIA meeting, FDA deputy commissioner for operations and chief operating officer, Janet Woodcock announced that, CDISC (Clinical Data Interchange Standards Consortium) will lead a collaborative group of industry stakeholders to focus on the Critical Path Opportunity to enable standardized collection of clinical research data at investigative sites. Dr. Woodcock said, “The industry needs consensus on the definition of high quality data and that standardization is...